128 related articles for article (PubMed ID: 25594762)
1. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762
[TBL] [Abstract][Full Text] [Related]
2. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H
Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.
Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2015 Jan; 6(3):1582-93. PubMed ID: 25638160
[TBL] [Abstract][Full Text] [Related]
4. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
6. Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.
Kawahara T; Inoue S; Kashiwagi E; Chen J; Ide H; Mizushima T; Li Y; Zheng Y; Miyamoto H
Am J Cancer Res; 2017; 7(10):2041-2050. PubMed ID: 29119053
[TBL] [Abstract][Full Text] [Related]
7. GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens.
Li Y; Ishiguro H; Kawahara T; Miyamoto Y; Izumi K; Miyamoto H
Am J Cancer Res; 2014; 4(5):461-73. PubMed ID: 25232488
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
Kashiwagi E; Inoue S; Mizushima T; Chen J; Ide H; Kawahara T; Reis LO; Baras AS; Netto GJ; Miyamoto H
Br J Cancer; 2018 Jan; 118(2):213-223. PubMed ID: 29123257
[TBL] [Abstract][Full Text] [Related]
10. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation.
Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
Transpl Infect Dis; 2014 Jun; 16(3):379-86. PubMed ID: 24666466
[TBL] [Abstract][Full Text] [Related]
11. ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor.
Inoue S; Ide H; Mizushima T; Jiang G; Kawahara T; Miyamoto H
Am J Cancer Res; 2018; 8(11):2325-2336. PubMed ID: 30555747
[TBL] [Abstract][Full Text] [Related]
12. Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
Ding W; Tong Y; Zhang X; Pan M; Chen S
Sci Rep; 2016 Jan; 6():19793. PubMed ID: 26795951
[TBL] [Abstract][Full Text] [Related]
13. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
14. NFAT and Osterix cooperatively regulate bone formation.
Koga T; Matsui Y; Asagiri M; Kodama T; de Crombrugghe B; Nakashima K; Takayanagi H
Nat Med; 2005 Aug; 11(8):880-5. PubMed ID: 16041384
[TBL] [Abstract][Full Text] [Related]
15. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
Sommerer C; Zeier M; Meuer S; Giese T
Transplantation; 2010 Jun; 89(11):1417-23. PubMed ID: 20463649
[TBL] [Abstract][Full Text] [Related]
16. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
18. ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Kawahara T; Inoue S; Ide H; Kashiwagi E; Ohtake S; Mizushima T; Li P; Li Y; Zheng Y; Uemura H; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2016 Aug; 7(33):53599-53610. PubMed ID: 27447553
[TBL] [Abstract][Full Text] [Related]
19. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
